One of the projects that I photographed with Microsoft last year was Station B.
Microsoft is creating a platform and bringing together partners to program biological systems, essentially understanding how to program cells like we program computers and eventually control how a cell behaves. Instead of programming in 1s and 0s researchers are using the building blocks of DNA to write “programs” that could, for instance, help a cell recognize and attack cancer. This can open doors to new treatments, drugs, cures and materials. The industry holds huge promise but still faces a number of challenges.
Microsoft is leveraging its expertise in programming and research to develop systems with state of the art programming languages, algorithms and machine learning methods to program cells; something few companies have the capabilities and research infrastructure to do.
Microsoft is partnering with researchers at Princeton University in the US and two UK companies – Oxford BioMedica, which focuses on gene and cell therapy, and Synthace, which develops scientific software – as it develops the new system, called Station B.
The project is featured in the Financial Times